Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heparin Induced Thrombocytopenia (HIT)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Not applicableUnknownNCT00510432
What this trial is testing

Incidence and Nature of Heparin-induced Skin Lesions in Medical Patients

Who this might be right for
Allergy
Johann Wolfgang Goethe University Hospital 500
Large-scale testing (Phase 3)Study completedNCT00198588
What this trial is testing

Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia

Who this might be right for
Heparin-Induced Thrombocytopenia
Ministry of Health, Labour and Welfare, Japan 8
Not applicableStudy completedNCT02790567
What this trial is testing

Rapid Diagnosis of Heparin-Induced Thrombocytopenia in Surgical Critically Ill Patients

Who this might be right for
Heparin-induced Thrombocytopenia (HIT)
Centre Hospitalier Universitaire de Besancon 120
Large-scale testing (Phase 3)Study completedNCT00079508
What this trial is testing

Angiomax in Patients With HIT/HITTS Type II Undergoing CPB

Who this might be right for
Cardiovascular DiseaseCoronary Artery Bypass Surgery
The Medicines Company 125
Early research (Phase 1)Study completedNCT00489437
What this trial is testing

Heparin-Induced Thrombocytopenia Score Card Study

Who this might be right for
Heparin-Induced Thrombocytopenia
McMaster University 536
Large-scale testing (Phase 3)Study completedNCT00043940
What this trial is testing

Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning)

Who this might be right for
Heparin-Induced ThrombocytopeniaThrombosis
The Medicines Company 50
Testing effectiveness (Phase 2)Temporarily pausedNCT02501434
What this trial is testing

Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin

Who this might be right for
Aneurysmal Subarachnoid HemorrhageNeurobehavioral ManifestationsVasospasm, Intracranial+2 more
Robert F. James 88
Not applicableStudy completedNCT00456001
What this trial is testing

Heparin Induced Thrombocytopenia: Pharmacoeconomics

Who this might be right for
Heparin Induced Thrombocytopenia (HIT)
Brigham and Women's Hospital 200
Large-scale testing (Phase 3)UnknownNCT03147638
What this trial is testing

Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-induced Thrombocytopenia
Marshall University 70
Not applicableEnded earlyNCT00594685
What this trial is testing

Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study)

Who this might be right for
Thrombocytopenia
Carelon Research 10
Not applicableStudy completedNCT01178333
What this trial is testing

Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study

Who this might be right for
Heparin Induced Thrombocytopenia
Carelon Research 668